Related Experiment Videos

A possible role for multidrug resistance-associated protein in the secretion of basic fibroblast growth factor by

S Aggarwal1, S Gupta

  • 1Division of Basic and Clinical Immunology, University of California, Irvine, CA 92697, USA.

Insights

The multidrug resistance-associated protein (MRP) may facilitate the secretion of basic fibroblast growth factor (bFGF) from osteogenic sarcoma cells. Inhibiting MRP reduced bFGF secretion, suggesting a role in its transport.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Basic fibroblast growth factor (bFGF) is crucial for cell growth and differentiation.
  • The secretion mechanism for bFGF is not well understood due to the absence of a signal sequence.
  • Multidrug resistance-associated proteins (MRPs) are known transporters of various molecules.

Purpose of the Study:

  • To investigate the potential role of MRP in the secretion of bFGF.
  • To determine if osteogenic sarcoma MG-63 cells express MRP and if it influences bFGF secretion.

Main Methods:

  • MG-63 cells, known to secrete bFGF, were analyzed for MRP expression at the protein and mRNA levels.
  • The effect of probenecid, an MRP inhibitor, on bFGF secretion was assessed.
  • Intracellular bFGF levels were measured in the presence of probenecid.

Main Results:

  • MG-63 cells were confirmed to express MRP at both the protein and mRNA levels.
  • Probenecid treatment inhibited bFGF secretion in a concentration-dependent manner.
  • Inhibition of secretion by probenecid led to an increased intracellular accumulation of bFGF.

Conclusions:

  • The findings suggest that MRP plays a role in the secretion of bFGF from MG-63 cells.
  • MRP may function as a transporter for bFGF, explaining its non-classical secretion pathway.

Related Concept Videos